{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:39:24Z","timestamp":1781307564509,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jneuroim.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,9]],"date-time":"2017-04-09T10:45:20Z","timestamp":1491734720000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Central and peripheral nervous system immune-mediated demyelinating disease after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"307","author":[{"given":"M.I.","family":"Stefanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jneuroim.2017.04.005_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pediatrneurol.2014.07.007","article-title":"Neuromyelitis optica in an adolescent after bone marrow transplantation","volume":"52","author":"Baumer","year":"2015","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.04.005_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-012-0962-9","article-title":"Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease","volume":"110","author":"Delios","year":"2012","journal-title":"J. Neuro-Oncol."},{"issue":"8","key":"10.1016\/j.jneuroim.2017.04.005_bb0015","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bmt.2015.84","article-title":"Late post-transplant anti-aquaporin-4 ab-positive optic neuritis in a patient with AML","volume":"50","author":"Diamanti","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.jneuroim.2017.04.005_bb0020","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus Conference on clinical practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jneuroim.2017.04.005_bb0025","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2012-09-456590","article-title":"The central nervous system is a target of acute graft versus host disease in mice","volume":"121","author":"Hartrampf","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.04.005_bb0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.04.005_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bmt.1705540","article-title":"Central nervous system graft-versus-host disease: report of two cases and literature review","volume":"39","author":"Kamble","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.04.005_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.bmt.1705709","article-title":"Central nervous system graft-versus-host disease presenting with granulomatous encephalitis","volume":"40","author":"Kew","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jneuroim.2017.04.005_bb0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jneuroim.2017.04.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"16","key":"10.1016\/j.jneuroim.2017.04.005_bb0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2169\/internalmedicine.48.2003","article-title":"Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"48","author":"Matsuo","year":"2009","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.jneuroim.2017.04.005_bb0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0046-8177(96)90010-6","article-title":"Neuropathologic findings after bone marrow transplantation: an autopsy study","volume":"21","author":"Mohrmann","year":"1990","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.04.005_bb0065","first-page":"633","article-title":"Immune-mediated myelopathy after allogeneic marrow transplantation","volume":"15","author":"Openshaw","year":"1995","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.04.005_bb0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410430511","article-title":"Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation","volume":"43","author":"Padovan","year":"1998","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2017.04.005_bb0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.STR.30.8.1651","article-title":"Angiitis of the central nervous system after allogeneic bone marrow transplantation?","volume":"30","author":"Padovan","year":"1999","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.04.005_bb0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.04.005_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"30","key":"10.1016\/j.jneuroim.2017.04.005_bb0090","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1200\/JCO.2009.21.7919","article-title":"Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation","volume":"27","author":"Saad","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.04.005_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2004-861537","article-title":"Neurological complications of hematopoietic cell transplantation","volume":"24","author":"Saiz","year":"2004","journal-title":"Semin. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.04.005_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1532\/IJH97.06060","article-title":"Immune-mediated myelopathy following allogeneic stem cell transplantation","volume":"84","author":"Sakai","year":"2006","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.04.005_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1468-1331.2001.00160.x","article-title":"Central and peripheral nervous system complications following allogeneic bone marrow transplantation","volume":"8","author":"Solaro","year":"2001","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.04.005_bb0110","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","article-title":"Prospective evaluation of neurological complications after allogeneic bone marrow transplantation","volume":"60","author":"Sostak","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.04.005_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.jneuroim.2017.04.005_bb0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2377-10-76","article-title":"Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases","volume":"10","author":"Voss","year":"2010","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.04.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.04.005_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2017.04.005_bb0135","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.04.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817300012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817300012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:30:21Z","timestamp":1759048221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817300012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"alternative-id":["S0165572817300012"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.04.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central and peripheral nervous system immune-mediated demyelinating disease after allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}